Norihiko Shiraishi

Company: NANO MRNA Co., Ltd.

Job title: Executive Officer, Chief Scientific Officer & mRNA IPG Unit Head

Seminars:

Targeting lncRNA TUG1 for Treatment of Patients with GBM by Using a Novel DDS for ASO – New Data 4:30 pm

Presenting a novel drug delivery system for antisense oligonucleotides Achieving success in non-clinical experiments Showcasing early clinical resultsRead more

day: Day Two